Your browser doesn't support javascript.
loading
Pan-cancer efficacy and safety of anlotinib plus PD-1 inhibitor in refractory solid tumor: A single-arm, open-label, phase II trial.
Qin, Bao-Dong; Jiao, Xiao-Dong; Wang, Zhan; Liu, Ke; Wu, Ying; Ling, Yan; Chen, Shi-Qi; Zhong, Xue; Duan, Xiao-Peng; Qin, Wen-Xing; Xue, Lei; Guo, Zhen-Hong; Zang, Yuan-Sheng.
Afiliação
  • Qin BD; Department of Medical Oncology, Changzheng Hospital, Naval Medical University, Shanghai, China.
  • Jiao XD; Department of Medical Oncology, Changzheng Hospital, Naval Medical University, Shanghai, China.
  • Wang Z; Department of Medical Oncology, Changzheng Hospital, Naval Medical University, Shanghai, China.
  • Liu K; Department of Medical Oncology, Changzheng Hospital, Naval Medical University, Shanghai, China.
  • Wu Y; Department of Medical Oncology, Changzheng Hospital, Naval Medical University, Shanghai, China.
  • Ling Y; Department of Medical Oncology, Changzheng Hospital, Naval Medical University, Shanghai, China.
  • Chen SQ; Department of Medical Oncology, Changzheng Hospital, Naval Medical University, Shanghai, China.
  • Zhong X; Department of Medical Oncology, Changzheng Hospital, Naval Medical University, Shanghai, China.
  • Duan XP; Department of Medical Oncology, Changzheng Hospital, Naval Medical University, Shanghai, China.
  • Qin WX; Department of Medical Oncology, Changzheng Hospital, Naval Medical University, Shanghai, China.
  • Xue L; Department of Thoracic Surgery, Changzheng Hospital, Naval Medical University, Shanghai, China.
  • Guo ZH; National Key Laboratory of Medical Immunology & Institute of Immunology, Naval Medical University, Shanghai, China.
  • Zang YS; Department of Medical Oncology, Changzheng Hospital, Naval Medical University, Shanghai, China.
Int J Cancer ; 153(4): 815-825, 2023 08 15.
Article em En | MEDLINE | ID: mdl-37155342
Assuntos
Palavras-chave
Texto completo
Adicionar na Minha BVS
Imprimir
XML
PubMed Links
Buscar no Google

Texto completo: 1 Coleções: 01-internacional Base de dados: MEDLINE Assunto principal: Quinolinas / Neoplasias Limite: Humans Idioma: En Revista: Int J Cancer Ano de publicação: 2023 Tipo de documento: Article País de afiliação: China
Texto completo
Adicionar na Minha BVS
Imprimir
XML
PubMed Links
Buscar no Google

Texto completo: 1 Coleções: 01-internacional Base de dados: MEDLINE Assunto principal: Quinolinas / Neoplasias Limite: Humans Idioma: En Revista: Int J Cancer Ano de publicação: 2023 Tipo de documento: Article País de afiliação: China